Login

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q3 FY2016
As of Sep 30, 2016
Q2 FY2016
As of Jun 30, 2016
Q1 FY2016
As of Mar 31, 2016
Q4 FY2015
As of Dec 31, 2015
Q3 FY2015
As of Sep 30, 2015
Q2 FY2015
As of Jun 30, 2015
Q1 FY2015
As of Mar 31, 2015
Q4 FY2014
As of Dec 31, 2014
Q3 FY2014
As of Sep 30, 2014
Q2 FY2014
As of Jun 30, 2014
Assets
Current assets:
Cash and cash equivalents
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Property, equipment and software, net
Deferred offering costs
Deferred tax assets
Restricted cash
Other assets
Total assets
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable
Accrued liabilities
Convertible note
Note payable, net of discount
Convertible preferred stock warrant liability
Deferred revenue
Deferred tax liabilities
Line of credit
Short-term debt
Other current liabilities
Total current liabilities
Deferred rent
Note payable, net of current portion and discount
Other liabilities
Note payable, net of current portion
Long-term debt
Total liabilities
Stockholders’ equity:
Preferred stock; $0.001 par value; 10,000 shares authorized and 0 outstanding as of September 30, 2016 and December 31, 2015
Series A
Series A-1
Series B
Series C
Common stock; $0.001 par value; 200,000 shares authorized and 36,652 and 35,344 shares issued and outstanding as of September 30, 2016 and December 31, 2015, respectively
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support